Dendritic Cell Therapy

Dendritic Cell Therapy is one of the groundbreaking clinical cancer treatments that are being highlighted among the medical community.  Let us explain how and why we offer DCV in our clinic. Anytime you have questions, feel free to text us at

Dendritic Cell Therapy boosts the numbers by taking some immature Dendritic Cells from the patient’s own blood and cultivating, processing, and activating them in the laboratory. It is a complex and highly specialized process that only a few laboratories can perform. In the end, the patient receives certification on quality to get the very best quality of cells.

Dendritic Cell therapy is one of the immunotherapy treatments which are changing the landscape of how we think about managing advanced disease

How does the DCV affect cancer cells?

  1. The impact of DCV on tumor cells is not direct but based on the reprogramming of the antitumor immune response, which is a complicated multistage process.
  2. Dendritic cells are a type of immune cells that play very important role in starting the immune response – circulating in the blood as monocytes they are the first to come into contact with a presentable antigen, becoming activated into mature dendritic cells and then migrating to the lymph nodes, where they interact with other elements of the immune system.
  3. Monocytes are isolated from the patient’s blood, then a mixture of tumor-derived peptide antigens is added to the cell culture in the lab. After this maturation dendritic cells are now presenting specific tumor antigens on their surface and, when reintroduced back into patient’s blood, they trigger other types of immune cells – the T and B cells – to destroy the cancer cells specifically.

1. Request the treatment (by phone or in an electronic form) supplemented with your medical information:

      • records of medical history,
      • latest general clinical and biochemical blood test.

2. Based on these documents, doctors will make an assessment of your health condition and make the decision on the suitability of the therapy.

Why do patients choose DCV?

Dendritic Cell Therapy is a powerful form of immunotherapy used to fight cancer. The dendritic cell is the most potent of all antigen-presenting immune cells.

Their job is to break down cancer cells so the T-cells can then identify and attack them. Dendritic Cells are seldom active in adequate numbers to get this immune response in the face of active cancer.

This type of Dendritic Cell Therapy is targeted therapy. The particular tumour markers are cultured as well as trained, and therefore are tumor specific. This is a more advanced procedure than just training the Dendritic Cells.